All the news Showing 10 of 213 articles from: Pharmaceutical industryGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources India to launch national program to control viral hepatitis and aims to negotiate lower drug prices Pharma Letter / 09 January 2018 Hepatitis C: In Argentina INPI rejected a key patent on Sofosbuvir Fundación Grupo Efecto Positivo / 05 December 2017 Gilead prices hepatitis C giant Sovaldi in China at one-fifth the US price: report FiercePharma / 29 November 2017 Medicines Excitement in the Netherlands – New Health Minister announces firm action on “absurd” medicines pricing Medicines Law & Policy / 27 November 2017 Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics TAG / 01 November 2017 Gilead HCV drug sales down in 2017 third quarter compared with 2016 Healio / 31 October 2017 Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty Intellectual Property Watch / 26 October 2017 Merck targets high-risk military veterans for hepatitis C lessons Fierce Pharma / 16 October 2017 UK pharma denied legal challenge to drugs bill cap Pharmaphorum / 05 October 2017 The Hepatitis Drug Market Is Worse Than Wall Street Realises Bloomberg / 04 October 2017 ← Prev1...34567...22Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive